# FDA recall D-1485-2014

> **Pfizer Inc.** · Class III · drug recall initiated 2014-06-19.

## Product

Cardura XL (doxazosin mesylate extended release tablets, 4 mg, 30-count bottle, Rx only, Distributed by Roerig Division of Pfizer Inc., New York, NY 10017,  NDC 0049-2710-30

## Reason for recall

Failed Impurities/Degradation Specifications: Product from this lot may not meet specifications for a product degradant.

## Distribution

Nationwide (Continental USA and Puerto Rico).  A portion of the bulk lot was supplied to Pfizer Germany for packaging into blisters for non- USA market.  One of these lots in Germany was placed in stability having acceptable results, therefore are not part of the recall scope.  Only the product distributed within US/PR market (bottles) is in the scope of this recall.

## Key facts

- **Recall number:** D-1485-2014
- **Recalling firm:** Pfizer Inc.
- **Classification:** Class III
- **Product type:** drug
- **Status:** Terminated
- **Initiation date:** 2014-06-19
- **Report date:** 2014-08-06
- **Termination date:** 2015-06-03

- **Voluntary/Mandated:** Voluntary: Firm initiated
- **Location:** New York, NY, United States

## Primary source

FDA Enforcement Reports: https://www.accessdata.fda.gov/scripts/ires/index.cfm?Product=D-1485-2014

## Citation

> AI Analytics. FDA recall D-1485-2014. Retrieved 2026-05-27 from https://api.ai-analytics.org/recall/D-1485-2014. Source: US FDA. Licensed CC0.

---

*[Dataset catalog](/datasets/) · [FDA recalls dataset](/datasets/fda-recalls) · CC0 1.0*